Camurus AB (publ)

kr 731.00As of Sun 8 Nov 2026, 12:00 UTC
STO:CAMXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 23.41%
Div yield —
ROE 16.62%
Biotechnology
Beta (5Y) 0.42
PE TTM 58.11
TSR TTM 17.05%
Mkt cap kr 43.50B
ROIC 98.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 699
(4.42%)
(9.35%)
Hold 5|5|3|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
10.01
10.38
10.97
11.43
32.67%
33.23%
32.61%
24.20%
Revenuekr B
2.958
2.883
2.799
2.847
3.87%
3.43%
(2.66%)
(2.42%)
Peers (US$4.398B)
Cap (US$)
PE
2.756B
259.4x
4.470B
9.667x
Capital
TTM
5Y
10Y
Leveragex
0.272
0.031
0.027
EBIT/Intx
0.906
2.287
2.070
Own earn%
(233.56)
6.57
18.79
Sh yield%
24.26
32.57
30.74
Owners
Insiders/Inst%
10.98
65.62
Short interest%
3.07
SBC / revenue%
3.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
1–5
$1 testx
0.0
Incr. ROIC%
45